- Home
- VALU vs PRTC Comparison
VALU vs PRTC Comparison
Compare VALU & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- PRTC
- Stock Information
- Founded
- VALU 1931
- PRTC 2015
- Country
- VALU United States
- PRTC United States
- Employees
- VALU N/A
- PRTC N/A
- Industry
- VALU Investment Managers
- PRTC Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- PRTC Health Care
- Exchange
- VALU Nasdaq
- PRTC Nasdaq
- Market Cap
- VALU 510.6M
- PRTC 431.0M
- IPO Year
- VALU N/A
- PRTC N/A
- Fundamental
- Price
- VALU $45.90
- PRTC $17.50
- Analyst Decision
- VALU
- PRTC Buy
- Analyst Count
- VALU 0
- PRTC 1
- Target Price
- VALU N/A
- PRTC $45.00
- AVG Volume (30 Days)
- VALU 6.8K
- PRTC 3.7K
- Earning Date
- VALU 03-14-2025
- PRTC 08-28-2024
- Dividend Yield
- VALU 2.61%
- PRTC N/A
- EPS Growth
- VALU 26.35
- PRTC N/A
- EPS
- VALU 2.36
- PRTC N/A
- Revenue
- VALU $35,859,000.00
- PRTC $468,000.00
- Revenue This Year
- VALU N/A
- PRTC N/A
- Revenue Next Year
- VALU N/A
- PRTC $160.00
- P/E Ratio
- VALU $19.45
- PRTC N/A
- Revenue Growth
- VALU N/A
- PRTC N/A
- 52 Week Low
- VALU $36.00
- PRTC $17.00
- 52 Week High
- VALU $57.68
- PRTC $34.00
- Technical
- Relative Strength Index (RSI)
- VALU 31.00
- PRTC 34.98
- Support Level
- VALU $48.00
- PRTC $17.00
- Resistance Level
- VALU $49.82
- PRTC $18.21
- Average True Range (ATR)
- VALU 1.20
- PRTC 0.39
- MACD
- VALU -0.69
- PRTC -0.06
- Stochastic Oscillator
- VALU 1.77
- PRTC 16.85
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About PRTC PureTech Health plc
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.